← Back to Search

Other

Miebo for Dry Eye Syndrome

Phase 4
Recruiting
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at postop day 30 ± 7 days
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

This trial will look at how Miebo™ affects eye measurements before and after surgery.

Who is the study for?
This trial is for individuals with Dry Eye Syndrome who are preparing for eye surgery. The study aims to include those who need accurate measurements of their eyes (biometry/keratometry) before surgery and want to improve the precision of their vision after the operation.
What is being tested?
The study is testing Miebo™, a treatment designed to help with Dry Eye Syndrome. It's an open-label Phase 4 trial, meaning everyone knows they're getting Miebo™, and it's being conducted across multiple centers.
What are the potential side effects?
Since specific side effects aren't listed here, generally speaking, treatments for dry eye syndrome can sometimes cause mild burning or irritation in the eyes upon application.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at postop day 30 ± 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at postop day 30 ± 7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean difference between absolute deviations from predicted refractive error in the study eye.

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Miebo treatmentExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Miebo
2023
Completed Phase 4
~150

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
257 Previous Clinical Trials
58,130 Total Patients Enrolled
~67 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top